Third Institute of Oceanography, Ministry of Natural Resources, Xiamen, 361005, People's Republic of China.
College of the Environment & Ecology, Xiamen University, Xiang'an district, Xiamen, 361102, People's Republic of China.
World J Microbiol Biotechnol. 2023 Sep 25;39(11):318. doi: 10.1007/s11274-023-03752-8.
The present study evaluates the antibacterial properties of alkaloids and the crude extracts (ethanol, n-hexane and ethyl acetate) from seaweed Sargassum fusiforme against coral pathogens (Photobacterium galatheae, Vibrio harveyi, Bordetella trematum, and Ochrobactrum pseudogrignonese) isolated from coral Porites lutea. To our knowledge, this is the first in vitro assay for such extracts on Porites lutea coral pathogens. Bacterial pathogens have been identified using 16S RNA and BankIt into gene bank and given the accession numbers (OR401000; OR401001; OR401336, and OR400998 respectively). GC-Mass profiling conducted for n-hexane compounds confirmed the presence of thirty-eight molecules, twelve of which have been previously reported for their bioactivity. The results revealed that alkaloids and n-hexane extract demonstrated eminent antibacterial activity compared to the other extracts against the tested coral pathogenic bacteria. Molecular docking was conducted to evaluate the twelve previously mentioned bioactive molecules to get a full understanding of the interaction of those bioactive molecules on vital bacterial proteins (Hemolysin protein (PDB ID: 1XEZ) and Cytoplasmic proteins (PDB ID: 3TZC)). Docked twelve molecules against hemolysin protein (PDB ID: 1XEZ) came exactly in line with the docked result of the same molecules with cytoplasmic proteins (PDB ID: 3TZC), proving the bioactivity of 6-O-Palmitoyl-L-ascorbic acid, 3TMS derivative; Glycerol monostearate, 2TMS derivative and Eicosanoic acid complexes in antibacterial activity action and score higher than reference ligand. Those three compounds will be investigated separately in future in vitro assay soon. Our conclusions align with the study's antibacterial in vitro assay results. The present study reports the novelty of different extracts of S. fusiforme as an antibacterial agent against coral pathogenic bacteria that trigger diseases in Porites lutea.
本研究评估了来自 Sargassum fusiforme 的生物碱和粗提取物(乙醇、正己烷和乙酸乙酯)对从珊瑚 Porites lutea 中分离出的珊瑚病原体(Photobacterium galatheae、Vibrio harveyi、Bordetella trematum 和 Ochrobactrum pseudogrignonese)的抗菌特性。据我们所知,这是首次针对这种提取物对 Porites lutea 珊瑚病原体进行的体外检测。使用 16S RNA 和 BankIt 将细菌病原体鉴定并输入基因库,并分别获得了以下登录号(OR401000;OR401001;OR401336 和 OR400998)。对正己烷化合物进行的 GC-Mass 分析证实存在三十八种分子,其中有十二种以前曾因其生物活性而被报道过。结果表明,与其他提取物相比,生物碱和正己烷提取物对测试的珊瑚病原菌表现出显著的抗菌活性。进行了分子对接以评估这 12 种以前提到的生物活性分子,以充分了解这些生物活性分子对重要细菌蛋白(溶血蛋白(PDB ID:1XEZ)和细胞质蛋白(PDB ID:3TZC))的相互作用。对接的十二种分子与溶血蛋白(PDB ID:1XEZ)完全吻合,与同一分子与细胞质蛋白(PDB ID:3TZC)的对接结果吻合,证明了 6-O-棕榈酰-L-抗坏血酸、3TMS 衍生物;甘油单硬脂酸酯、2TMS 衍生物和二十烷酸复合物在抗菌活性作用中的生物活性,并且得分高于参考配体。这三种化合物将在未来的体外检测中分别进行进一步研究。我们的结论与研究的抗菌体外检测结果一致。本研究报道了来自 S. fusiforme 的不同提取物作为抗珊瑚病原菌的抗菌剂的新颖性,这些珊瑚病原菌会引发 Porites lutea 疾病。